Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary CirrhosisInterventions: Biological: NGM282; Biological: PlaceboSponsors: NGM Biopharmaceuticals, Inc; NGM Biopharmaceuticals Australia Pty LtdRecruiting - verified March 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials